Press releases

The global cardiovascular research community is joining forces: eleven leading and independent funding organisations from Australia, Canada, Denmark, France, Germany, New Zealand, the Netherlands, Sweden, and the United Kingdom have joined forces to form the Global Cardiovascular...

Read more

Temporarily discontinuing ACE inhibitors and angiotensin receptor blockers does not affect the severity of COVID-19 disease, but it could have a beneficial effect on the recovery phase. Pausing could be particularly useful in elderly cardiovascular patients, suggest the authors...

Read more

Exercise in polluted air above a certain threshold may cause cardiovascular side effects because high levels of particulate matter. This proves a recent study from South Korea with almost 1.5 million young adults.

Read more

Atrial fibrillation, a common heart rhythm disorder, does not come back as quickly in obese people if they lose weight after catheter ablation, which is standard therapy for symptomatic atrial fibrillation. This is shown by the SORT-AF study, supported by the German Centre for...

Read more

Revacept is a novel platelet inhibitor that binds specifically to injured blood vessels and can be used safely during catheter interventions. This is now demonstrated in a study enrolling patients with narrowed coronary arteries co-funded by the German Centre for Cardiovascular...

Read more

Recovering from a corona infection at home - that's what most people want to do. But sometimes hospitalization is unavoidable. But when is the right time for this? This is being investigated by the COVID SMART study at LMU Klinikum München. Anyone who has risk factors for a...

Read more

A small, wearable heart monitor can detect atrial fibrillation in high-risk patients ten times more frequently than standard tests. This is the result of a new trans-Atlantic study involving researchers from Canada and Germany.

Read more

Cardiac arrhythmias were the most common cardiovascular problem in hospitalized COVID-19 patients. This is shown in an evaluation by scientists of the German Centre for Cardiovascular Research (DZHK) at the Department of Cardiology, Angiology and Pneumology at Heidelberg...

Read more

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used to treat patients with heart failure. After regulatory approval, recruitment of the first patient for the first-in-class, first-in-patient BioVAT-HF-DZHK20 early...

Read more

Diastolic heart failure can be reliably detected with a newly developed magnetic resonance imaging (MRI) technology, shows a study by the German Centre for Cardiovascular Research (DZHK) at the Göttingen site. Until now, this was only possible with a heart catheterisation study,...

Read more